Its activation might be promoted by tumor-intrinsic mechanisms mediated by receptor tyrosine kinases, such as HER2/erbB2 [9] or induced by its principle activator IFN-γ produced by immune cells. The gene discussed is NTRK1; the disease is neoplasm.